Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07554560 · ClinicalTrials.gov registry record · NA
Nutrition Intervention for Pancreatic Cancer
A NA study, sponsored by Children's Hospital of Philadelphia.
- Recruiting
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT07554560 is a NA study that is actively recruiting participants, run by Children's Hospital of Philadelphia. The registered enrollment target is 18 participants.
The verdict
NCT07554560, a NA study, is actively recruiting participants, sponsored by Children's Hospital of Philadelphia.
- RECRUITING
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
Patients with pancreatic cancer (pancreatic ductal adenocarcinoma (PDAC) and pancreatic neuroendocrine tumor (NET)) commonly experience fat malabsorption due to exocrine pancreatic insufficiency (EPI) and leads to gastrointestinal (GI) symptoms, malnutrition, weight loss, and reduced quality of life (QoL). Current standard treatment, pancreatic enzyme replacement therapy (PERT), is limited by suboptimal adherence, high cost, and partial effectiveness to prevent fat malabsorption. The objective of the study is to assess the feasibility and maintenance of lipid absorption function of a structured lipid medical food (SLMF; Encala®) powder in subjects with PDAC and NET with EPI.
Interventions
- OTHER Structured Lipid Medical Food
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2026-04-07 |
| Est. Completion | 2027-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07554560
The ClinicalTrials.gov registry entry for NCT07554560 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital of Philadelphia, which has 431 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Structured Lipid Medical Food is the first listed.
NCT07554560 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07554560 about?
NCT07554560 is a clinical study titled "Nutrition Intervention for Pancreatic Cancer". Patients with pancreatic cancer (pancreatic ductal adenocarcinoma (PDAC) and pancreatic neuroendocrine tumor (NET)) commonly experience fat malabsorption due to exocrine pancreatic insufficiency (EPI) and leads to gastrointestinal (GI) symptoms, malnutrition, weight loss, and reduced quality of life...
What is the current status of trial NCT07554560?
This trial is currently recruiting. It is a NA study. The enrollment target is 18 participants. The study started on 2026-04-07. Estimated completion is 2027-06.
What interventions are being tested in trial NCT07554560?
The interventions under investigation include: Structured Lipid Medical Food (OTHER).
Who is sponsoring clinical trial NCT07554560?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.